APA (7th ed.) Citation

CH, H., MY, H., CF, L., CC, L., YH, K., YT, H., . . . WJ, L. (2026). Programmable local immunochemotherapy for triple-negative breast cancer via spatiotemporally controlled release of CpG oligodeoxynucleotides, gemcitabine, and paclitaxel. NPJ breast cancer, 12(1), . https://doi.org/10.1038/s41523-026-00910-7

Chicago Style (17th ed.) Citation

CH, Hsieh, Hsu MY, Lin CF, Liu CC, Kuo YH, Huang YT, Chen WY, Liu SJ, and Lee WJ. "Programmable Local Immunochemotherapy for Triple-negative Breast Cancer via Spatiotemporally Controlled Release of CpG Oligodeoxynucleotides, Gemcitabine, and Paclitaxel." NPJ Breast Cancer 12, no. 1 (2026). https://doi.org/10.1038/s41523-026-00910-7.

MLA (9th ed.) Citation

CH, Hsieh, et al. "Programmable Local Immunochemotherapy for Triple-negative Breast Cancer via Spatiotemporally Controlled Release of CpG Oligodeoxynucleotides, Gemcitabine, and Paclitaxel." NPJ Breast Cancer, vol. 12, no. 1, 2026, https://doi.org/10.1038/s41523-026-00910-7.